abstract |
The invention relates to compounds of Formula (IIg) or a salt, solvate or prodrug thereof, wherein R 3 , X and Z 1 are as described in the specification, methods of preparing them and their use for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes. |